Trial Profile
A randomized, double-blind, prospective, placebo-controlled study of red clover isoflavones enriched with formononetin in postmenopausal women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs P 081 (Primary) ; Red clover isoflavones
- Indications Menopausal syndrome
- Focus Therapeutic Use
- 24 Sep 2015 New trial record